Explore Vesugen dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions.
Vesugen is a short synthetic peptide bioregulator (Lys-Glu-Asp) from the Khavinson family of organ-specific peptides, studied in Russian-language literature for its proposed regulatory effect on vascular-wall tissue and blood-vessel health. This data shows the dose amounts, vial sizes, and diluent volumes researchers most commonly select when reconstituting Vesugen.
Vesugen is a synthetic Lys-Glu-Asp (KED) tripeptide from the Khavinson program, sourced for vascular-tissue and aging research. It ships as a lyophilized powder you reconstitute before use, so the real vendor difference is what the certificate of analysis (COA) shows.
In the Khavinson framework, Vesugen is proposed to act through direct binding to gene-promoter DNA in vascular endothelial cells, selectively modulating transcription of genes involved in angiogenesis, endothelial-barrier function, and antioxidant defense. This proposed direct-DNA-binding mechanism is unconventional and has not been independently characterised outside the Khavinson group.
Russian work has reported Vesugen in age-related vascular endothelial dysfunction and in cell-culture and rodent models of impaired angiogenesis, with reported improvements in endothelial-function markers and vessel-density measures versus standard care. These studies are predominantly single-laboratory and have not been independently replicated outside the Khavinson programme; no Western Phase 2 or 3 trial has been registered.
Vesugen has a reported half-life of ~30 min (short-peptide estimate), and the dose intervals researchers model most often fall around once daily (in 10–20 day courses). This Khavinson tripeptide (Lys-Glu-Asp) clears within an hour, so there is no systemic buildup; the bioregulator effect is attributed to the course rather than a steady blood level. It is catalogued under Recovery Peptides on WPA.
20 Vesugen reconstitution calculations have been logged by the WPA community. The most common dose entered is 1mg (7 calculations). The most common bacteriostatic water volume is 3mL. The most popular vial size is 20mg (18 sessions). The most common dosing frequency is 2x/week (1 logged protocols), followed by 3x/week (1).
These figures come from anonymized WPA peptide calculator sessions.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.